Gravar-mail: PDCT-19. A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAF(V600E), IN CHILDREN WITH RECURRENT/REFRACTORY BRAF(V600E) MUTANT BRAIN TUMORS: PNOC-002